Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Dominik Paul Modest

24PUBLICATIONS
117CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEcological economicsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

Sort by Publication Date:
|Jul 09, 2026
Immune evasion in locally advanced mismatch repair-deficient microsatellite instability-high colorectal cancer: Reduced T-cell infiltration and upregulation of epithelial IDO1 expression.

|Mar 20, 2026
Requirements for a successful implementation of liver transplantation as a treatment option for non-resectable colorectal liver metastases into clinical routine - a narrative review.

Kilian Alexander Walter, Simon Moosburner, Tabea Kreutz

|Jan 05, 2026
Deep Learning-Derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-type Metastatic Colorectal Cancer.

Julius Keyl, René Hosch, Fabian Hörst

|Nov 18, 2025
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer.

Arndt Stahler, Dominik Paul Modest, Sebastian Stintzing

|Sep 29, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.

Alessandra Raimondi, Gabriele Tinè, Alexej Ballhausen

|Sep 04, 2025
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials.

Marco Maria Germani, Beatrice Borelli, Tadayoshi Hashimoto

Pageof 4

Frequent Collaborators

12 joint publications

Sebastian Stintzing

10 joint publications

Arndt Stahler

8 joint publications

Volker Heinemann

7 joint publications

Annika Kurreck

6 joint publications

Lothar Müller

5 joint publications

Ullrich Graeven

4 joint publications

Anke Reinacher-Schick

4 joint publications

Annabel Helga Sophie Alig

4 joint publications

David Horst

4 joint publications

Filippo Pietrantonio

Frequent Collaborators

12 joint publications

Sebastian Stintzing

10 joint publications

Arndt Stahler

8 joint publications

Volker Heinemann

7 joint publications

Annika Kurreck